全球肉毒桿菌毒素市场：按类型、用途- 预测 2023-2030

全球肉毒桿菌毒素市场规模预计将以15.46%的复合年增长率大幅成长，到2023年将达到493,408万美元，到2030年将达到13,516.74百万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球肉毒桿菌毒素市场至关重要。透过检验业务策略和产品满意度等关键指标，它可以对供应商进行全面评估，使用户能够根据自己的特定需求做出资讯的决策。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对整体收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解自家公司在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球肉毒桿菌毒素市场规模及预测是多少？

2.在预测期内，COVID-19 影响全球肉毒桿菌市场的阻碍因素和影响为何？

3. 在预测期内，全球肉毒桿菌毒素市场需要投资哪些产品/细分市场/应用/领域？

4.全球肉毒桿菌毒素市场的竞争策略是什么？

5. 全球肉毒桿菌毒素市场的技术趋势和法律规范是什么？

6.全球肉毒桿菌毒素市场主要供应商的市占率是多少？

7. 哪些型态和策略措施被认为适合进入全球肉毒桿菌毒素市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 非侵入性美容手术的数量正在增加
    • 越来越多的人开始注重自己的外表
    • 随着人口高龄化的增加，对使皮肤看起来更年轻的治疗的需求也增加。
  • 抑制因素
    • 手续费用相对昂贵
  • 机会
    • 产品核可和新产品发布的增加
    • 人们对肉毒毒素的治疗和美容应用的认识不断提高
  • 任务
    • 此过程可能产生的副作用
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章肉毒桿菌毒素市场：依类型

• A型肉毒桿菌毒素
• A型肉毒桿菌毒素
• A型肉毒桿菌毒素
• 利马肉毒桿菌B

第7章肉毒桿菌毒素市场：依用途

• 为了美丽
• 治疗性的
  • 眼睑痉挛
  • 下肢痉挛的马蹄足
  • 单侧面部痉挛
  • 膀胱过动症和神经源性膀胱
  • 原发性腋窝多汗症
  • 痉挛性发声困难
  • 痉挛性斜颈
  • 斜视
  • 上肢和下肢痉挛

第8章北美、南美肉毒桿菌毒素市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第9章亚太地区肉毒桿菌毒素市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第10章欧洲、中东和非洲肉毒桿菌毒素市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第11章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第12章上市公司名单

第13章附录

• 讨论指南
• 关于许可证和定价

The Global Botulinum Toxins Market is forecasted to grow significantly, with a projected USD 4,934.08 million in 2023 at a CAGR of 15.46% and expected to reach a staggering USD 13,516.74 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Botulinum Toxins Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Botulinum Toxins Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across AbobotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA, and RimabotulinumtoxinB. The OnabotulinumtoxinA is projected to witness significant market share during forecast period.

Based on Application, market is studied across Aesthetic and Therapeutic. The Therapeutic is further studied across Blepharospasm, Equinus Foot Associated With Lower Limb Spasticity, Hemifacial Spasm, Overactive Bladder & Neurogenic Bladder, Primary Axillary Hyperhidrosis, Spasmodic Dysphonia, Spasmodic Torticollis, Strabismus, and Upper & Lower Limb Spasticity. The Aesthetic is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Botulinum Toxins Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Botulinum Toxins Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Botulinum Toxins Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Botulinum Toxins Market?

4. What is the competitive strategic window for opportunities in the Global Botulinum Toxins Market?

5. What are the technology trends and regulatory frameworks in the Global Botulinum Toxins Market?

6. What is the market share of the leading vendors in the Global Botulinum Toxins Market?

7. What modes and strategic moves are considered suitable for entering the Global Botulinum Toxins Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Botulinum Toxins Market, by Type, 2022 vs 2030
• 4.3. Botulinum Toxins Market, by Application, 2022 vs 2030
• 4.4. Botulinum Toxins Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of non-invasive cosmetic procedures
    • 5.1.1.2. Increasing individuals highly conscious of their appearance
    • 5.1.1.3. Rising aging population demand for procedures to make their skin look young
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively high cost of the procedure
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing number of product approvals and launch of novel products
    • 5.1.3.2. Surging awareness of therapeutic and cosmetic application of botulinum toxin
  • 5.1.4. Challenges
    • 5.1.4.1. Probable side effects of the procedure
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Botulinum Toxins Market, by Type

• 6.1. Introduction
• 6.2. AbobotulinumtoxinA
• 6.3. IncobotulinumtoxinA
• 6.4. OnabotulinumtoxinA
• 6.5. RimabotulinumtoxinB

7. Botulinum Toxins Market, by Application

• 7.1. Introduction
• 7.2. Aesthetic
• 7.3. Therapeutic
  • 7.3.1. Blepharospasm
  • 7.3.2. Equinus Foot Associated With Lower Limb Spasticity
  • 7.3.3. Hemifacial Spasm
  • 7.3.4. Overactive Bladder & Neurogenic Bladder
  • 7.3.5. Primary Axillary Hyperhidrosis
  • 7.3.6. Spasmodic Dysphonia
  • 7.3.7. Spasmodic Torticollis
  • 7.3.8. Strabismus
  • 7.3.9. Upper & Lower Limb Spasticity

8. Americas Botulinum Toxins Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Botulinum Toxins Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Botulinum Toxins Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. BOTULINUM TOXINS MARKET RESEARCH PROCESS
• FIGURE 2. BOTULINUM TOXINS MARKET SIZE, 2022 VS 2030
• FIGURE 3. BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. BOTULINUM TOXINS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. BOTULINUM TOXINS MARKET DYNAMICS
• FIGURE 8. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. BOTULINUM TOXINS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. BOTULINUM TOXINS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BOTULINUM TOXINS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BOTULINUM TOXINS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. BOTULINUM TOXINS MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. BOTULINUM TOXINS MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BOTULINUM TOXINS MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. BOTULINUM TOXINS MARKET SIZE, BY RIMABOTULINUMTOXINB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 10. BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 12. BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BOTULINUM TOXINS MARKET SIZE, BY BLEPHAROSPASM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BOTULINUM TOXINS MARKET SIZE, BY EQUINUS FOOT ASSOCIATED WITH LOWER LIMB SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. BOTULINUM TOXINS MARKET SIZE, BY HEMIFACIAL SPASM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. BOTULINUM TOXINS MARKET SIZE, BY OVERACTIVE BLADDER & NEUROGENIC BLADDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. BOTULINUM TOXINS MARKET SIZE, BY PRIMARY AXILLARY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. BOTULINUM TOXINS MARKET SIZE, BY SPASMODIC DYSPHONIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. BOTULINUM TOXINS MARKET SIZE, BY SPASMODIC TORTICOLLIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. BOTULINUM TOXINS MARKET SIZE, BY STRABISMUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. BOTULINUM TOXINS MARKET SIZE, BY UPPER & LOWER LIMB SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CHINA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. ITALY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. POLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. QATAR BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 149. BOTULINUM TOXINS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 150. BOTULINUM TOXINS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 151. BOTULINUM TOXINS MARKET LICENSE & PRICING